FDA hands Akorn its fourth 483

The FDA has issued Akorn a Form 483, following an inspection of the drugmaker ' s manufacturing plant in New York, just weeks after Akorn received a warning letter for its Illinois site.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news